News

U.S. Department of Commerce Intends to Invest $169 Million in Tech Hubs Funding to Enhance Economic Competitiveness and National Security

Today, the U.S. Department of Commerce announced that the Economic Development Administration (EDA) intends to award $169 million across six selected Tech Hubs to advance U.S. leadership in industries essential to our economic competitiveness and national security.

These projects are part of EDA’s Regional Technology and Innovation Hubs (Tech Hubs) program, which serves as a key investment in this Administration’s America First agenda, investing in regions with the talent and assets to become global leaders in the critical technologies of the future.

The selected Tech Hubs are:

  • Advanced Pharmaceutical Manufacturing Tech Hub (Virginia)
    $16 million to develop and scale advanced, AI-enabled domestic pharmaceutical manufacturing.
  • Bloch Quantum Tech Hub (Illinois, Indiana, Wisconsin)
    $30 million to scale U.S. production of quantum materials, components, and subsystems.
  • Critical Minerals and Materials for Advanced Energy Tech Hub (Missouri)
    $38 million to boost the region’s ability to convert locally sourced minerals into critical materials essential for advanced manufacturing.
  • Forest Bioproducts Advanced Manufacturing Tech Hub (Maine)
    $20 million to unite state, university, industry, and workforce partners to strengthen domestic supply chains for sustainable forest‑based technologies.
  • Intermountain-West Nuclear Energy Corridor Tech Hub (Idaho, Wyoming)
    $31 million to accelerate reactor deployment, speed commercialization of next-generation reactors, and enhance U.S. energy security.
  • Kansas City BioSecure Manufacturing Tech Hub (Kansas, Missouri)
    $34 million to modernize manufacturing processes, strengthen and retool domestic supply chains, and accelerate the translation of biologic discoveries into scalable, resilient, and agile U.S. production.

“President Trump remains firmly committed to strengthening American manufacturing and ensuring that jobs are created and remain in in the United States. Today’s $169 million in EDA awards will advance critical manufacturing processes in pharmaceuticals, critical minerals, and nuclear energy, while accelerating the deployment of emerging technologies,” said U.S. Secretary of Commerce Howard Lutnick.

“Through strategic investments with local backing, the Tech Hubs program empowers U.S. regions to emerge as global leaders in critical technologies over the next decade,” said Deputy Assistant Secretary and Chief Operating Officer Ben Page, performing the nonexclusive duties and functions of the Assistant Secretary. “Once fully implemented, these projects will spur long‑term economic growth, strengthen domestic supply chains, and drive America’s leadership in critical technologies that will define global competitiveness for decades.”

Read more here.

Recent News

07/20/2026

U.S. Department of Commerce Intends to Invest $169 Million in Tech Hubs Funding to Enhance Economic Competitiveness and National Security

Today, the U.S. Department of Commerce announced that the Economic Development Administration (EDA) intends to award $169 million across six selected Tech Hubs to advance U.S. leadership in industries essential to our economic competitiveness and national security. These projects are part of EDA’s Regional Technology and Innovation Hubs (Tech Hubs) program, which serves as a key investment in this Administration’s America First agenda, investing in regions

07/15/2026

Focused Ultrasound Foundation Chairman Receives Lifetime Impact Award

Neal F. Kassell, MD, founder and chairman of the Focused Ultrasound Foundation, received the inaugural Lifetime Impact Award at the 2026 annual meeting of the International Society for Therapeutic Ultrasound (ISTU) in Norway in June. The award honors individuals whose work has fundamentally shaped the development, adoption, and global impact of focused ultrasound. “Dr. Kassell’s

07/14/2026

ARPA-H awards up to $160 million to advance personalized curative medicines for rare genetic diseases

The Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, today announced the teams for the Treating Hereditary Rare Diseases with In Vivo Precision Genetic Medicines (THRIVE) program — a critical investment toward bringing new treatments to patients faster and cure rare genetic pediatric diseases. THRIVE